Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 30 of 31

COMPLETED Phase 2

Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)

NCT00455325

COMPLETED Phase 2

Testosterone Therapy After Hip Fracture in Elderly Women

NCT00280267

COMPLETED NA

Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules

NCT00537797

COMPLETED Phase 2

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

NCT00324259

TERMINATED NA

Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

NCT00565916

TERMINATED Phase 3

Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant

NCT00241345

COMPLETED Phase 1

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

NCT00241358

COMPLETED Phase 4

Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients

NCT00550693

COMPLETED NA

Evaluation of Accelerated Partial Breast Brachytherapy

NCT00593346

COMPLETED NA

Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM

NCT00577590

COMPLETED Phase 2

Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer

NCT00084396

COMPLETED NA

Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer

NCT00081094

COMPLETED Early Phase 1

A Clinical Trial of Ginseng in Diabetes

NCT00781534

COMPLETED NA

Social Support and Education in Asthma Follow-up (SSEA)

NCT00149500

COMPLETED NA

A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study

NCT00895154

COMPLETED NA

Positron Emission Tomography in Prostate Cancer

NCT00121212

COMPLETED NA

Effect of Weight Loss on Myocardial Metabolism and Cardiac Relaxation in Obese Adults

NCT00572624

TERMINATED Phase 2

A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy

NCT00590967

COMPLETED NA

Study of Prophylactic Vs Preemptive Valganciclovir

NCT00374686

COMPLETED NA

Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia

NCT00552500

COMPLETED Phase 3

Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

NCT00057681

COMPLETED Phase 4

Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids

NCT00205712

COMPLETED Phase 3

Weight Loss and Exercise in Physically Limited Obese Elderly Subjects

NCT00146133

TERMINATED Phase 2

Clinical Application of Image-Guided Liver Surgery

NCT00878215

COMPLETED NA

The Impact of an Antimicrobial Utilization Program on Antimicrobial Use

NCT00552838

COMPLETED Phase 1

Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors

NCT00869843

COMPLETED Phase 2

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

NCT00242203

COMPLETED Phase 2

Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma

NCT00682786

COMPLETED Phase 2

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

NCT00660699

COMPLETED Phase 2

Chemotherapy and Radiation Following Pancreatic Surgery

NCT00660270

COMPLETED Phase 2

Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer

NCT00660140

COMPLETED NA

Treatment of Depression After Coronary Bypass Surgery

NCT00042198

COMPLETED NA

Glucose and Lipid Metabolism on Antipsychotic Medication

NCT00515723

COMPLETED NA

Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity

NCT00217854

TERMINATED NA

Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years

NCT00353184

COMPLETED

Epidemiology of Surfactant Protein-B Deficiency

NCT00014859

COMPLETED Phase 3

Effects of DHEA and Exercise in the Elderly

NCT00205686

COMPLETED NA

Pfizer/IVGTT/Ziprasidone/Olanzapine

NCT00205725

COMPLETED NA

Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone

NCT00374764

COMPLETED NA

Janssen - Glucose Regulation/Risp/Olanz

NCT00205738

COMPLETED

Sex and Obesity: Effects on Heart Failure Study

NCT00776035

TERMINATED

Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema

NCT00675454

TERMINATED Phase 1

Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy

NCT00006220

COMPLETED Phase 1

Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia

NCT00008697

COMPLETED Phase 2

Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

NCT00004176

COMPLETED NA

Recombinant Human Leptin Therapy Effects on Insulin Action

NCT01207934

COMPLETED Phase 1

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

NCT00003207

COMPLETED Phase 1

The Psychological Treatment of Overweight Binge Eaters Minority Supplement

NCT01208259

COMPLETED Phase 3

Case Management and Environmental Control in Asthma

NCT00514436

COMPLETED Phase 3

Coaching in Childhood Asthma

NCT00910585

← Previous Page 30 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.